ASP-7657
- Generic Name
- ASP-7657
A Study to Assess the Safety and Tolerability, Including Gastrointestinal Safety, Pharmacokinetics and Pharmacodynamics of ASP7657 in Caucasian Healthy Male and Female Subjects
Phase 1
Terminated
- Conditions
- Pharmacokinetics of ASP7657Pharmacodynamics of ASP7657Healthy Subjects
- Interventions
- First Posted Date
- 2014-04-09
- Last Posted Date
- 2015-03-27
- Lead Sponsor
- Astellas Pharma Europe B.V.
- Target Recruit Count
- 89
- Registration Number
- NCT02108548
- Locations
- 🇬🇧
Parexel Early Phase Clinical Unit, Harrow, Middlesex, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath